Morgan Lewis Advised Cencora On $7.4 Billion Acquisition Of Oneoncology

Morgan Lewis Advised Cencora on $7.4 Billion Acquisition of OneOncology

Morgan Lewis is advised Cencora on a definitive agreement to acquire the majority of outstanding equity interest that it does not currently own in OneOncology from TPG. The transaction values the OneOncology enterprise at $7.4 billion, with an equity value of approximately $6 billion.

Cencora is a global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. OneOncology is a national physician-led platform empowering independent medical specialty practices rooted in oncology.

The Morgan Lewis team led by Aaron Suh (Partner), and Lindsay Mozdziock (Associate) are advised Cencora with respect to the acquisition while Andrew Budreika (Partner), and Benjamin Stango (Associate) are advising on the financing. The team includes Jim McKenzie (Partner), Crystal Fang (Partner), Harry Robins (Partner), Susan Zhu (Partner), Patrick Rehfield (Partner), and Paul Gordon (Partner),Timothy Durbin (Of counsel), and Erin O'Gurek (Associate), Alyssa Cavallo (Associate), Fleur de Jong (Associate), Ann Reynolds (Associate), Emma Drake (Associate), and Andreas Andrews (Associate).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.